A personalized DVH prediction model for HDR brachytherapy in cervical cancer treatment

被引:5
|
作者
Li, Zhen [1 ]
Chen, Kehui [2 ]
Yang, Zhenyu [3 ]
Zhu, Qingyuan [1 ]
Yang, Xiaojing [1 ]
Li, Zhaobin [1 ]
Fu, Jie [1 ]
机构
[1] Shanghai Jiao Tong Univ, Peoples Hosp 6, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Shanghai, Peoples R China
[3] Duke Univ, Durham, NC USA
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
machine learning; brachytherapy; cervical cancer; dose prediction; radiation oncology; RADIATION-THERAPY; DOSE PREDICTION; QUALITY; TOOL;
D O I
10.3389/fonc.2022.967436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeAlthough the knowledge-based dose-volume histogram (DVH) prediction has been largely researched and applied in External Beam Radiation Therapy, it is still less investigated in the domain of brachytherapy. The purpose of this study is to develop a reliable DVH prediction method for high-dose-rate brachytherapy plans. MethodA DVH prediction workflow combining kernel density estimation (KDE), k-nearest neighbor (kNN), and principal component analysis (PCA) was proposed. PCA and kNN were first employed together to select similar patients based on principal component directions. 79 cervical cancer patients with different applicators inserted was included in this study. The KDE model was built based on the relationship between distance-to-target (DTH) and the dose in selected cases, which can be subsequently used to estimate the dose probability distribution in the validation set. Model performance of bladder and rectum was quantified by |Delta D-2cc|, |Delta D-1cc|, |Delta D-0.1cc|, |Delta D-max|, and |Delta D-mean| in the form of mean and standard deviation. The model performance between KDE only and the combination of kNN, PCA, and KDE was compared. Result20, 30 patients were selected for rectum and bladder based on KNN and PCA, respectively. The absolute residual between the actual plans and the predicted plans were 0.38 +/- 0.29, 0.4 +/- 0.32, 0.43 +/- 0.36, 0.97 +/- 0.66, and 0.13 +/- 0.99 for |Delta D-2cc|, |Delta D-1cc|, |Delta D-0.1cc|, |Delta D-max|, and |Delta D-mean| in the bladder, respectively. For rectum, the corresponding results were 0.34 +/- 0.27, 0.38 +/- 0.33, 0.63 +/- 0.57, 1.41 +/- 0.99 and 0.23 +/- 0.17, respectively. The combination of kNN, PCA, and KDE showed a significantly better prediction performance than KDE only, with an improvement of 30.3% for the bladder and 33.3% for the rectum. ConclusionIn this study, a knowledge-based machine learning model was proposed and verified to accurately predict the DVH for new patients. This model is proved to be effective in our testing group in the workflow of HDR brachytherapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] A Knowledge-Based Machine Learning Model for DVH Prediction in HDR Brachytherapy
    Li, Z.
    Zhu, Q.
    Li, Z.
    Fu, J.
    Yang
    MEDICAL PHYSICS, 2022, 49 (06) : E185 - E185
  • [2] Direction Modulated Brachytherapy for HDR Treatment of Cervical Cancer
    Han, D.
    Webster, M.
    Scanderbeg, D.
    Yashar, C.
    Choi, D.
    Song, B.
    Devic, S.
    Ravi, A.
    Song, W.
    MEDICAL PHYSICS, 2014, 41 (06) : 90 - 90
  • [3] HDR brachytherapy and EBT of cervical cancer
    Cikaric, S
    BALKAN CONGRESS OF ONCOLOGY, 1996, : 281 - 286
  • [4] Comparision Of Two Hdr Intracavitary Brachytherapy Regimens In Treatment Of Cervical Cancer
    Krishna, A.
    Ag, H.
    Fernandes, D.
    Ms, A.
    Rao, S.
    Shankar, S.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S46 - S47
  • [5] Verifying the treatment planning system in individualized HDR brachytherapy of cervical cancer
    Van den Bosch, M.
    Vanneste, B.
    Voncken, R.
    Lutgens, L.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S521 - S521
  • [6] Vaginal mucosal doses in the treatment of cervical cancer using HDR brachytherapy
    Keough, W.
    Bleakley, L.
    White, L.
    Zahra, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S932 - S933
  • [7] Dose Volume Histograms (DVH) Analysis and Comparison with ICRU Point Doses in MRI Guided HDR Brachytherapy for Cervical Cancer
    Badkul, R.
    McClinton, C.
    Kumar, P.
    Mitchell, M.
    MEDICAL PHYSICS, 2014, 41 (06) : 348 - 348
  • [8] Automated DIR for Cervical Cancer HDR Brachytherapy
    Ackerman, C.
    Palomo, A. Medina
    Park, D.
    Scanderbeg, I.
    Mayadev, J.
    Melt, L.
    Cervino, L.
    MEDICAL PHYSICS, 2018, 45 (06) : E504 - E504
  • [9] Adaptive MRI Image Guided HDR Brachytherapy Treatment Planning for Cervical Cancer
    Apicelli, A. J.
    Dyk, P.
    Sun, B.
    Bertelsman, C.
    Kavanaugh, J.
    DeWees, T.
    Garcia-Ramirez, J.
    Richardson, S.
    Schwarz, J. K.
    Grigsby, P. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S437 - S438
  • [10] HDR Interstitial CT based Brachytherapy For the Treatment of Cervical Cancer: Early Results
    Kannan, N.
    Beriwal, S.
    Kim, H.
    Houser, C.
    Mogus, R.
    Sukumvanich, P.
    Olawaiye, A. B.
    Richard, S.
    Kelley, J. L.
    Edwards, R. P.
    Edwards, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S455 - S455